12th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190083385 | PRODUCTION METHOD AND EFFERVESCENT FORMULATIONS COMPRISING CEPHALOSPORIN AND CLAVULANIC ACID | 2019-03-21 |
20190083386 | METHODS AND FORMULATIONS FOR TRANSDERMAL ADMINISTRATION OF BUFFERING AGENTS | 2019-03-21 |
20190083387 | TOPICAL REGIONAL NEURO AFFECTIVE THERAPY WITH CANNABINOID COMBINATION PRODUCTS | 2019-03-21 |
20190083388 | SYNTHENTIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS | 2019-03-21 |
20190083389 | HYDROGEL MICROPARTICLE SCAFFOLD WITH GRADIENTS OF DEGRADABILITY AND METHODS THEREOF | 2019-03-21 |
20190083390 | RicinoLAX Rectal Stimulant Laxative | 2019-03-21 |
20190083391 | ORALLY DISINTEGRATING TABLETS FOR TREATMENT OF PEPTIC ULCER | 2019-03-21 |
20190083392 | COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF DISORDERS OF THE ORAL CAVITY, UPPER AIRWAYS AND ESOPHAGUS | 2019-03-21 |
20190083393 | SNUFF COMPOSITION | 2019-03-21 |
20190083394 | DRY POWDER FORMULATIONS FOR INHALATION | 2019-03-21 |
20190083395 | BREATHING ENHANCEMENT DEVICE | 2019-03-21 |
20190083396 | UNIT DOSES, AEROSOLS, KITS, AND METHODS FOR TREATING HEART CONDITIONS BY PULMONARY ADMINISTRATION | 2019-03-21 |
20190083397 | OIL-IN-WATER EMULSIONS INCLUDING RETINOIC ACID | 2019-03-21 |
20190083398 | RGD PEPTIDE AND PENETRATING PEPTIDE R8 CO-MODIFIED ERGOSTEROL AND CISPLATIN ACTIVE DRUG-LOADING LIPOSOME | 2019-03-21 |
20190083399 | DRUG DELIVERY COMPOSITION | 2019-03-21 |
20190083400 | Crosslinked Polysaccharide Beads and Their Biomedical Uses | 2019-03-21 |
20190083401 | NUTRITIONAL AND MEDICINAL ORAL COMPOSITION FOR VETERINARY USE | 2019-03-21 |
20190083402 | PROCESS FOR LYOPHILIZED PHARMACEUTICAL FORMULATION OF A THERAPEUTIC PROTEIN | 2019-03-21 |
20190083403 | Orally Disintegrating Tablet Formulation For Enhanced Bioavailability | 2019-03-21 |
20190083404 | PHARMACEUTICAL MATRIX FORMULATIONS COMPRISING DIMETHYL FUMARATE | 2019-03-21 |
20190083405 | INGESTIBLE PRODUCT AND A METHOD OF USING THE SAME | 2019-03-21 |
20190083406 | GALENIC FORMULATIONS OF ORGANIC COMPOUNDS | 2019-03-21 |
20190083407 | CRYSTALLIZATION METHOD AND BIOAVAILABILITY | 2019-03-21 |
20190083408 | CONTROLLED-RELEASE PEPTIDE COMPOSITIONS AND USES THEREOF | 2019-03-21 |
20190083409 | ORAL COMPOSITE FORMULATION COMPRISING FAT-SOLUBLE DRUG AND SOLID PREPARATION COATED WITH OIL REPELLENT BASE | 2019-03-21 |
20190083410 | PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN | 2019-03-21 |
20190083411 | PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN | 2019-03-21 |
20190083412 | COILED TUBE EMULSIFICATION SYSTEMS AND METHODS | 2019-03-21 |
20190083413 | Anti-Inflammatory Pharmaceutical Compositions and Methods of Administration | 2019-03-21 |
20190083414 | NANOCAPSULES COMPRISING A LIPOSOLUBLE ACTIVE INGREDIENT, PRODUCTION AND USES | 2019-03-21 |
20190083415 | SUSTAINED DRUG RELEASE SHEET FOR TREATING NERVE INJURY | 2019-03-21 |
20190083416 | TRANSDERMAL DEVICE INCLUDING POROUS MICROPARTICLES | 2019-03-21 |
20190083417 | COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES | 2019-03-21 |
20190083418 | USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY | 2019-03-21 |
20190083419 | TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH REDOX-ACTIVE THERAPEUTICS | 2019-03-21 |
20190083420 | METHODS OF USING (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE IN THE TREATMENT OF DEPRESSION, ANXIETY, ANHEDONIA, FATIGUE, SUICIDAL IDEATION, AND POST TRAUMATIC STRESS DISORDERS | 2019-03-21 |
20190083421 | METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS | 2019-03-21 |
20190083422 | SENSE-33 COMPOSITIONS AND METHODS THEREOF FOR ENHANCING THE EXPRESSION AND/OR ACTIVITY OF NICOTINIC ACETYLCHOLINE RECEPTORS | 2019-03-21 |
20190083423 | METHOD OF REDUCING NEURONAL CELL DEATH WITH HALOALKYLAMINES | 2019-03-21 |
20190083424 | FORMULATION FOR INHIBITING FORMATION OF 5-HT2B AGONISTS AND METHODS OF USING SAME | 2019-03-21 |
20190083425 | FORMULATION FOR INHIBITING FORMATION OF 5-HT2B AGONISTS AND METHODS OF USING SAME | 2019-03-21 |
20190083426 | COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC EFFECTS | 2019-03-21 |
20190083427 | METHODS AND MATERIALS FOR REDUCING ISCHEMIA-REPERFUSION INJURY | 2019-03-21 |
20190083428 | SALT BALANCED VAGINAL PRODUCT AND METHOD | 2019-03-21 |
20190083429 | TOPICAL FERTILITY PROMOTING PRODUCT AND MANUFACTURING METHOD | 2019-03-21 |
20190083435 | Oral Microbiota Promotion for Immune System Associated Inflammations | 2019-03-21 |
20190083436 | METHODS OF DIAGNOSING CANCER | 2019-03-21 |
20190083437 | S- Methylcysteine Sulfoxide For Prostate Cancer Prevention And Treatment | 2019-03-21 |
20190083438 | ACETYL-LEUCINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR IMPROVED MOBILITY AND COGNITIVE FUNCTION | 2019-03-21 |
20190083439 | USE OF BIPOLAR TRANS CAROTENOIDS WITH CHEMOTHERAPY AND RADIOTHERAPY FOR TREATMENT OF CANCER | 2019-03-21 |
20190083440 | METHODS AND COMPOSITIONS FOR TREATING INFECTION AND INFLAMMATION WITH SELENOCYANATE | 2019-03-21 |
20190083441 | TREATMENT OF DISEASE WITH ESTERS OF SELECTIVE RXR AGONISTS | 2019-03-21 |
20190083442 | GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD | 2019-03-21 |
20190083443 | INGENOL COMPOUNDS AND USE THEREOF IN ANTI-HIV LATENCY TREATMENT | 2019-03-21 |
20190083444 | METHODS OF REDUCING APOLIPOPROTEIN C-III | 2019-03-21 |
20190083445 | METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY | 2019-03-21 |
20190083446 | TOPICAL FORMULATIONS OF CHLOROPROCAINE AND METHODS OF USING SAME | 2019-03-21 |
20190083447 | REDUCTION OF GASTROINTESTINAL TRACT COLONISATION BY CAMPYLOBACTER | 2019-03-21 |
20190083448 | COMPOSITIONS AND FORMULATIONS INCLUDING CABAZITAXEL AND HUMAN SERUM ALBUMIN | 2019-03-21 |
20190083449 | COMBINATION THERAPY WITH AN ANTI-HYALURONAN AGENT AND THERAPEUTIC AGENT | 2019-03-21 |
20190083450 | DERIVATIVES OF KORORMICIN USEFUL AS ANTIBIOTICS | 2019-03-21 |
20190083451 | SYNERGISTIC EFFECT OF ANTI-TROP-2 ANTIBODY-DRUG CONJUGATE IN COMBINATION THERAPY FOR TRIPLE-NEGATIVE BREAST CANCER WHEN USED WITH MICROTUBULE INHIBITORS OR PARP INHIBITORS | 2019-03-21 |
20190083452 | THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS | 2019-03-21 |
20190083453 | COMPOSITION COMPRISING NAPHTHOQUINONE-BASED COMPOUND AS ACTIVE INGREDIENT, FOR PREVENTING OR AMELIORATING FATIGUE, CACHEXIA, PAIN, COGNITIVE DECLINE AND HEMATOPOIETIC STEM CELL REDUCTION WHICH ARE SIDE EFFECTS RELATED TO ANTICANCER DRUG TREATMENT | 2019-03-21 |
20190083454 | PERINATAL TREATMENT WITH A FLAVONOID AGONIST OF THE TRKB RECEPTOR FOR BDNF RESCUES NEUROGENESIS AND BEHAVIOR IN THE TS65DN MOUSE MODEL OF DS | 2019-03-21 |
20190083455 | METHODS AND COMPOSITIONS FOR THE MODULATION OF BETA-ENDORPHIN LEVELS | 2019-03-21 |
20190083456 | COMPOSITION FOR BKCA CHANNEL ACTIVATION | 2019-03-21 |
20190083457 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS FOR PROTECTING, EXPANDING AND INCREASING THE POTENCY OF HEMATOPOIETIC STEM CELLS | 2019-03-21 |
20190083458 | Andrographolide Treats Progressive Forms of Multiple Sclerosis | 2019-03-21 |
20190083459 | PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2019-03-21 |
20190083460 | ANALGESIC COMPOUNDS | 2019-03-21 |
20190083461 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES | 2019-03-21 |
20190083462 | PREVENTION OF NSAID ENTEROPATHY WITH MICROBIOTA-DERIVED TRYPTOPHAN-METABOLITE | 2019-03-21 |
20190083463 | EDARAVONE DOSAGE FORM | 2019-03-21 |
20190083464 | SYSTEMS AND METHODS TO TREAT PAIN LOCALLY | 2019-03-21 |
20190083465 | Methods And Compositions For Treating Foot Or Hand Pain | 2019-03-21 |
20190083466 | NOVEL USE OF BIOTIN AND NATURAL ESSENTIAL OILS FOR BOVINE ANIMALS TO IMPROVE BEEF QUALITY | 2019-03-21 |
20190083467 | AROMATIC RING COMPOUND | 2019-03-21 |
20190083468 | METHODS OF TREATMENT FOR CHOLESTATIC AND FIBROTIC DISEASES | 2019-03-21 |
20190083469 | METHOD OF TREATING MULTIPLE SCHLEROSIS EMPLOYING A LSD1-INHIBITOR | 2019-03-21 |
20190083470 | P38 MAP KINASE INHIBITORS FOR TREATING FRIEDREICH'S ATAXIA | 2019-03-21 |
20190083471 | BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ZOLIPIDEM | 2019-03-21 |
20190083472 | SECURININE AND NORSECURININE ANALOGUE COMPOUNDS FOR THE TREATMENT OF MYELOID DISORDERS | 2019-03-21 |
20190083473 | AZABICYCLOOCTANE DERIVATIVES AS FXR AGONISTS FOR USE IN THE TREATMENT OF LIVER AND GASTROINTESTINAL DISEASES | 2019-03-21 |
20190083474 | AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS | 2019-03-21 |
20190083475 | PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A PI3 DELTA OR DUAL PI3 DELTA-GAMMA KINASE INHIBITOR | 2019-03-21 |
20190083476 | ENHANCERS OF NOTCH SIGNALING AND THE USE THEREOF IN THE TREATMENT OF CANCERS AND MALIGNANCIES MEDICABLE BY UPREGULATION OF NOTCH | 2019-03-21 |
20190083477 | Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures | 2019-03-21 |
20190083478 | Choline salt forms of an HIV capsid inhibitor | 2019-03-21 |
20190083479 | COMBINATION MEDICATION | 2019-03-21 |
20190083480 | Treatment of Neurodegenerative Conditions by Disruption of Rhes | 2019-03-21 |
20190083481 | METHODS FOR USING FXR AGONISTS | 2019-03-21 |
20190083482 | PRMT5 INHIBITORS AND USES THEREOF | 2019-03-21 |
20190083483 | BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY | 2019-03-21 |
20190083484 | Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2 | 2019-03-21 |
20190083485 | METHODS FOR TREATING IMMUNODEFICIENCY DISEASE | 2019-03-21 |
20190083486 | THE USE OF GLUCOCORTICOID RECEPTOR MODULATORS TO POTENTIATE CHECKPOINT INHIBITORS | 2019-03-21 |
20190083487 | EFFICACY OF ANTI-HLA-DR ANTIBODY DRUG CONJUGATE IMMU-140 (hL243-CL2A-SN-38) IN HLA-DR POSITIVE CANCERS | 2019-03-21 |
20190083488 | COMPOSITIONS AND METHODS FOR MINIMIZING OR REVERSING AGONIST-INDUCED DESENSITIZATION | 2019-03-21 |
20190083489 | METHODS FOR INDUCING AN IMMUNE RESPONSE BY INHIBITION OF NONSENSE MEDIATED DECAY | 2019-03-21 |